{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:10:24Z","timestamp":1775902224447,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ando.2022.01.006","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T01:50:12Z","timestamp":1644198612000},"page":"226-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Management of thyrotoxicosis and pregnancy: Review of the current literature and an update of the care pathway"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5391-7582","authenticated-orcid":false,"given":"Philippe","family":"Caron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2022.01.006_bib0205","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2213-8587(13)70086-X","article-title":"Hyperthyroidism in pregnancy","volume":"1","author":"Cooper","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2022.01.006_bib0210","first-page":"1333","article-title":"The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum","volume":"75","author":"Goodwin","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.01.006_bib0215","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJM199812173392505","article-title":"Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin","volume":"339","author":"Rodien","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2022.01.006_bib0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2015-3670","article-title":"Prolonged and severe gestational thyrotoxicosis due to enhanced hCG sensitivity of a mutant thyrotropin receptor","volume":"101","author":"Coulon","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.01.006_bib0225","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/cen.14215","article-title":"New variant (Val597Ile) in transmembrane region of the TSH receptor with human chorionic gonadotropin hypersensitivity in familial gestational hyperthyroidism","volume":"93","author":"Caron","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2022.01.006_bib0230","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2213-8587(20)30061-9","article-title":"Association of maternal thyroid function with birth weight: a systematic review and individual-participant data meta-analysis","volume":"8","author":"Derakhshan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2022.01.006_bib0235","doi-asserted-by":"crossref","first-page":"dgaa555","DOI":"10.1210\/clinem\/dgaa555","article-title":"Maternal thyroid dysfunction during pregnancy and the risk of adverse outcomes in the offspring: a systematic review and meta-analysis","volume":"105","author":"Ge","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.01.006_bib0240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-8587(15)00327-7","article-title":"Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study","volume":"4","author":"Korevaar","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2022.01.006_bib0245","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/EJE-14-0254","article-title":"Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism","volume":"171","author":"Abeillon-du Payrat","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2022.01.006_bib0250","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/thy.2017.0413","article-title":"Maternal thyrotropin receptor antibody concentration and the risk of fetal and neonatal thyrotoxicosis: a systematic review","volume":"28","author":"van Dijk","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2022.01.006_bib0255","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/uog.6315","article-title":"Use of ultrasound to distinguish between fetal hyperthyroidism and hypothyroidism on discovery of a goiter","volume":"33","author":"Huel","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ando.2022.01.006_bib0260","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1530\/eje.0.1390584","article-title":"Guidelines for TSH receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association","volume":"139","author":"Laurberg","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2022.01.006_bib0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH receptor autoimmunity in Graves\u2019 disease after therapy with antithyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","author":"Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2022.01.006_bib0270","first-page":"311","article-title":"An unusual presentation of fulminant hepatic failure secondary to propylthiouracil therapy","author":"Morris","year":"1989","journal-title":"Clin Transpl"},{"key":"10.1016\/j.ando.2022.01.006_bib0275","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/106002800303700213","article-title":"Fulminant hepatic failure associated with propylthiouracil","volume":"37","author":"Ruiz","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ando.2022.01.006_bib0280","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM198607033150104","article-title":"Antithyroid drug therapy for Graves\u2019 disease during pregnancy. Optimal regimen for fetal thyroid status","volume":"315","author":"Momotani","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2022.01.006_bib0285","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EJE-14-0135","article-title":"Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk?","volume":"171","author":"Laurberg","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2022.01.006_bib0290","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ajmg.a.32497","article-title":"Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study","volume":"146A","author":"Barbero","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ando.2022.01.006_bib0295","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/qjmed\/hcq248","article-title":"Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy","volume":"105","author":"Bowman","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.ando.2022.01.006_bib0300","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2011-2860","article-title":"Treatment of Graves\u2019 disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation","volume":"97","author":"Yoshihara","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.01.006_bib0305","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2013-2831","article-title":"Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study","volume":"98","author":"Andersen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.01.006_bib0310","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/M17-1398","article-title":"Antithyroid drugs and congenital malformations: a nationwide Korean cohort study","volume":"168","author":"Seo","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2022.01.006_bib0315","doi-asserted-by":"crossref","first-page":"e0126610","DOI":"10.1371\/journal.pone.0126610","article-title":"Congenital anomalies in children exposed to antithyroid drugs in utero: a meta-analysis of cohort studies","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ando.2022.01.006_bib0320","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1471-0528.2011.03019.x","article-title":"Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study","volume":"118","author":"Chen","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.ando.2022.01.006_bib0325","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1089\/thy.2012.0488","article-title":"Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States","volume":"23","author":"Korelitz","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2022.01.006_bib0330","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1089\/thy.2014.0434","article-title":"Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system","volume":"25","author":"Lo","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2022.01.006_bib0335","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s40618-015-0281-z","article-title":"Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy","volume":"38","author":"Gianetti","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2022.01.006_bib0340","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-17-0314","article-title":"Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study","volume":"177","author":"Andersen","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2022.01.006_bib0345","doi-asserted-by":"crossref","first-page":"bvaa204","DOI":"10.1210\/jendso\/bvaa204","article-title":"Exposure to propylthiouracil in the first trimester of pregnancy and birth defects: a study at a single institution","volume":"5","author":"Yoshihara","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ando.2022.01.006_bib0350","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1089\/thy.2014.0581","article-title":"Substituting potassium iodide for methimazole as the treatment for Graves\u2019 disease during the first trimester may reduce the incidence of congenital anomalies: a retrospective study at a single medical institution in Japan","volume":"25","author":"Yoshihara","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2022.01.006_bib0355","doi-asserted-by":"crossref","first-page":"bvaa187","DOI":"10.1210\/jendso\/bvaa187","article-title":"Thyroid function of infants breast-fed by mothers with Graves\u2019 disease treated with inorganic iodine: a study of 100 cases","volume":"5","author":"Hamada","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ando.2022.01.006_bib0360","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/clinem\/dgab747","article-title":"Approach to the patient: fetal and neonatal thyroid dysfunction","volume":"107","author":"L\u00e9ger","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.01.006_bib0365","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12902-020-00663-9","article-title":"Unusual onset of thyroid associated orbitopathy during pregnancy: case report and review of literature","volume":"20","author":"Aranyosi","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ando.2022.01.006_bib0370","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/thy.2011.0087","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum","volume":"21","author":"Stagnaro-Green","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2022.01.006_bib0375","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2022.01.006_bib0380","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ando.2022.01.006_bib0385","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1210\/clinem\/dgaa945","article-title":"Testing, monitoring, and treatment of thyroid dysfunction in pregnancy","volume":"106","author":"Lee","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.01.006_bib0390","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1515\/JPEM.2003.16.9.1239","article-title":"Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole","volume":"16","author":"Azizi","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.01.006_bib0395","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1210\/jcem-55-1-108","article-title":"Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves\u2019 disease","volume":"55","author":"Amino","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2022.01.006_bib0400","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1210\/jc.2008-0966","article-title":"The effect of pregnancy on subsequent relapse from Graves\u2019 disease after a successful course of antithyroid drug therapy","volume":"93","author":"Rotondi","year":"2008","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426622000178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426622000178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:53:12Z","timestamp":1757717592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426622000178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0003426622000178"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2022.01.006","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of thyrotoxicosis and pregnancy: Review of the current literature and an update of the care pathway","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2022.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}